Rutz Michael P
Known title: President of SterigenicsCIK: 0001599220
Associated companies
Transaction History
| SHC | ▼ Sell | Open Market | 150,000 | $2.8M | 8/7/2026 | View on chart |
| SHC | ▲ Buy | Option Exercise | 14,573 | — | 3/2/2026 | View on chart |
| SHC | ▼ Sell | Tax Withholding | 3,729 | $59K | 3/2/2026 | View on chart |
| SHC | ▼ Sell | Tax Withholding | 4,495 | $72K | 3/2/2026 | View on chart |
| SHC | ▼ Sell | Tax Withholding | 17,497 | $278K | 3/2/2026 | View on chart |
| SHC | ▲ Buy | Grant | 45,223 | $0 | 3/2/2026 | View on chart |
| SHC | ▼ Sell | Open Market | 126,611 | $2.1M | 8/22/2025 | View on chart |
| SHC | ▲ Buy | Grant | 48,579 | $0 | 3/3/2025 | View on chart |
| SHC | ▼ Sell | Tax Withholding | 5,399 | $67K | 3/2/2025 | View on chart |
| SHC | ▼ Sell | Tax Withholding | 3,687 | $46K | 3/2/2025 | View on chart |
| SHC | ▼ Sell | Tax Withholding | 4,198 | $52K | 3/2/2025 | View on chart |
| SHC | ▼ Sell | Tax Withholding | 2,889 | $38K | 11/20/2024 | View on chart |
| SHC | ▲ Buy | Grant | 34,270 | $0 | 3/4/2024 | View on chart |
| SHC | ▼ Sell | Open Market | 83,109 | $1.2M | 3/4/2024 | View on chart |
| SHC | ▼ Sell | Tax Withholding | 2,438 | $35K | 3/2/2024 | View on chart |
| SHC | ▼ Sell | Tax Withholding | 3,063 | $45K | 3/2/2024 | View on chart |
| SHC | ▼ Sell | Tax Withholding | 1,911 | $27K | 11/20/2023 | View on chart |
| SHC | ▲ Buy | Grant | 28,425 | $0 | 3/6/2023 | View on chart |
| SHC | ▼ Sell | Tax Withholding | 2,948 | $51K | 3/2/2023 | View on chart |
| SHC | ▼ Sell | Tax Withholding | 1,911 | $12K | 11/20/2022 | View on chart |
| SHC | ▲ Buy | Grant | 24,962 | $0 | 3/2/2022 | View on chart |
| SHC | ▼ Sell | Tax Withholding | 1,911 | $43K | 11/20/2021 | View on chart |
| SHC | ▼ Sell | Open Market | 67,000 | $1.7M | 8/25/2021 | View on chart |
AI Market Commentary
AI-generatedAll commentary →Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.
October 16, 2026
SHC Downgraded to Underweight by JP Morgan, Price Target Set at $17
JP Morgan lowered its rating on Sotera Health to Underweight and issued a new price target of $17. The downgrade came after the company's recent earnings discussion, which highlighted its current operational performance. Observers also note that the stock has risen about 35% recently, raising questions about its valuation relative to the new target.
SHC Downgraded to Underweight by JP Morgan, Price Target Set at $17. JP Morgan lowered its rating on Sotera Health to Underweight and issued a new price target of $17. The downgrade came after the company's recent earnings discussion, which highlighted its current operational performance. Observers also note that the stock has risen about 35% recently, raising questions about its valuation relative to the new target.